News Daily News More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices Shelley Wood June 07, 2016
News Daily News Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis Michael O'Riordan June 07, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2016 Shelley Wood May 31, 2016
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
Presentation EuroPCR 2016 First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation Presenter: Danny Dvir May 19, 2016
News Conference News EuroPCR 2016 ‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices Caitlin E. Cox May 17, 2016
News Industry News St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology May 16, 2016
News Conference News EuroPCR 2016 EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’ Shelley Wood May 16, 2016
News Industry News Medtronic VenaSeal Closure System Demonstrates Long-Term Durability and Improved Quality of Life in Patients with Venous Reflux Disease April 28, 2016
News Industry News Medtronic Demonstrates Commitment to EVAR in Comparison Study of ENGAGE Global Registry and Landmark EVAR 1 Trial April 28, 2016
News Daily News Low BMI in and of Itself Portends Poor Survival After Acute MI Caitlin E. Cox April 21, 2016
News Industry News GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains Health Canada Approval April 21, 2016
News Industry News St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement April 07, 2016
News Conference News ACC 2016 Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients L.A. McKeown April 04, 2016
News Conference News ACC 2016 When Chosen Wisely, 90-Year-Olds Do Well After TAVR Caitlin E. Cox April 02, 2016
News Conference News ACC 2016 TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral Shelley Wood April 02, 2016
News Industry News New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control March 01, 2016
News Conference News CRT 2016 Will the MitraClip and Other Gadgets Make Headway in Functional MR? Shelley Wood February 25, 2016
News Daily News La Enfermedad de Tronco Coronario Izdo. Co-existente No Debería de Descartar Intervenciones TAVR L.A. McKeown February 22, 2016